£75.93

Springer Macro Roles for MicroRNAs in the Life and Death of Neurons (Research and Perspectives in Neurosciences)

Price data last checked 8 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£76 today · cheaper than every other day in the last 1 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 30 days · 30 data points (no recent data)

Historical
Generating forecast…
£78.58 £75.67 £76.30 £76.94 £77.57 £78.21 £78.85 01 July 2026 08 July 2026 15 July 2026 22 July 2026 30 July 2026

Price Distribution

Price distribution over 30 days • 2 price levels

Days at Price
Current Price
11 days · current 19 days 0 5 10 14 19 £76 £79 Days at Price

Price Analysis

Most common price: £79 (19 days, 63.3%)

Price range: £76 - £79

Price levels: 2 different prices over 30 days

Description

The discovery of microRNAs has revealed an unexpected and spectacular additional level of fine tuning of the genome and how genes are used again and again in different combinations to generate the complexity that underlies for instance the brain. Since the initial studies performed in C.elegans, we gave gone a far way to begin to understand how microRNA pathways can have an impact on health and disease in human. Although microRNAs are abundantly expressed in the brain, relatively little is known about the multiple functions of these RNA molecules in the nervous system. Nevertheless, we know already that microRNA pathways play major roles in the proliferation, differentiation, function and maintenance of neuronal cells. Several intriguing studies have linked microRNAs as major regulators of the neuronal phenotype, and have implicated specific microRNAs in the regulation of synapse formation and plasticity. Dysfunction of microRNA pathways is also slowly emerging as a potential important contributor to the pathogenesis of major neurodegenerative disorders such as Alzheimer s disease and Parkinson s disease. These novel insights appear to be particular promising for the understanding of the very frequent and badly understood sporadic forms of these diseases as compared to the genetic forms. Thus, the better understanding of the implications of this novel field of molecular biology is crucial for the broad area of neurosciences, from the fundamental aspects to the clinic, and from novel diagnostic to potentially therapeutic applications for severe neurological and maybe psychiatric diseases. From the Back Cover The discovery of microRNAs has revealed an unexpected and spectacular additional level of fine tuning of the genome and how genes are used again and again in different combinations to generate the complexity that underlies for instance the brain. Since the initial studies performed in C.elegans, we have gone a far way to begin to understand how microRNA pathways can have an impact on health and disease in human. Although microRNAs are abundantly expressed in the brain, relatively little is known about the multiple functions of these RNA molecules in the nervous system. Nevertheless, we know already that microRNA pathways play major roles in the proliferation, differentiation, function and maintenance of neuronal cells. Several intriguing studies have linked microRNAs as major regulators of the neuronal phenotype, and have implicated specific microRNAs in the regulation of synapse formation and plasticity. Dysfunction of microRNA pathways is also slowly emerging as a potential important contributor to the pathogenesis of major neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease. These novel insights appear to be particular promising for the understanding of the very frequent and badly understood sporadic forms of these diseases as compared to the genetic forms. Thus, the better understanding of the implications of this novel field of molecular biology is crucial for the broad area of neurosciences, from the fundamental aspects to the clinic, and from novel diagnostic to potentially therapeutic applications for severe neurological and maybe psychiatric diseases.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
18 December 2009
Listed Since
05 August 2009

Barcode

No barcode data available

Similar Products You Might Like

87% match

Epigenetics and miRNA in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications

Elsevier

£157.99 04 Aug 2026
RNA Metabolism in Neurodegenerative Diseases: 20 (Advances in Neurobiology, 20)
85% match

RNA Metabolism in Neurodegenerative Diseases: 20 (Advances in Neurobiology, 20)

Springer

£76.38 30 Jul 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
84% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£147.14 05 Aug 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
84% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£117.61 31 Jul 2026
Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)
84% match

Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)

Springer

£144.94 05 Aug 2026
Molecular Aspects of Neurobiology (Proceedings in Life Sciences)
84% match

Molecular Aspects of Neurobiology (Proceedings in Life Sciences)

Springer

£77.96 11 Jun 2026
Leucine-Rich Repeat Kinase 2 (LRRK2): 14 (Advances in Neurobiology, 14)
83% match

Leucine-Rich Repeat Kinase 2 (LRRK2): 14 (Advances in Neurobiology, 14)

Springer

£108.01 05 Aug 2026
Presenilins and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)
83% match

Presenilins and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)

Springer

£76.22 01 Jun 2026
Mitochondrial Dynamics and Neurodegeneration
83% match

Mitochondrial Dynamics and Neurodegeneration

Springer

£107.98 02 Jun 2026
Epigenetics, Brain and Behavior (Research and Perspectives in Neurosciences)
83% match

Epigenetics, Brain and Behavior (Research and Perspectives in Neurosciences)

Springer

£107.78 06 Jun 2026
Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)
83% match

Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)

Springer

£106.91 11 Jun 2026
Neurodegenerative Disorders: Loss of Function Through Gain of Function (Research and Perspectives in Alzheimer's Disease)
83% match

Neurodegenerative Disorders: Loss of Function Through Gain of Function (Research and Perspectives in Alzheimer's Disease)

Springer

£107.93 12 Jun 2026
Molecular and Cellular Mechanisms of Neuronal Plasticity: Basic and Clinical Implications: 446 (Advances in Experimental Medicine and Biology, 446)
82% match

Molecular and Cellular Mechanisms of Neuronal Plasticity: Basic and Clinical Implications: 446 (Advances in Experimental Medicine and Biology, 446)

Springer

£108.01 06 Aug 2026
Connections, Cognition and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)
82% match

Connections, Cognition and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)

Springer

£76.42 04 Aug 2026
miRNA in Human Disease: From Biomarkers to Therapeutics
82% match

miRNA in Human Disease: From Biomarkers to Therapeutics

Elsevier

£145.99 05 Aug 2026
Neuroprotection Methods and Protocols: 399 (Methods in Molecular Biology, 399)
82% match

Neuroprotection Methods and Protocols: 399 (Methods in Molecular Biology, 399)

Humana

£75.68 03 Jun 2026
Advances in Genomics and Neurosciences for Neurologic and Behavioral Disorders
82% match

Advances in Genomics and Neurosciences for Neurologic and Behavioral Disorders

Academic Press

£145.99 04 Aug 2026
82% match

Microglial Advances in Neurodegenerative Diseases (Volume 171) (Advances in Immunology, Volume 171)

Elsevier

£135.00 04 Aug 2026
Neuro-Immune Interactions in Neurologic and Psychiatric Disorders (Research and Perspectives in Neurosciences)
82% match

Neuro-Immune Interactions in Neurologic and Psychiatric Disorders (Research and Perspectives in Neurosciences)

Springer

£73.85 11 Jun 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
81% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£108.75 14 Jun 2026
The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume II: Neuroanatomical and Neuroimaging Endophenotypes and Biomarkers
81% match

The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume II: Neuroanatomical and Neuroimaging Endophenotypes and Biomarkers

Springer

£107.41 22 Jun 2026
Molecular and Cellular Mechanisms of Neuronal Plasticity: Basic and Clinical Implications: 446 (Advances in Experimental Medicine and Biology, 446)
81% match

Molecular and Cellular Mechanisms of Neuronal Plasticity: Basic and Clinical Implications: 446 (Advances in Experimental Medicine and Biology, 446)

Springer

£129.54 16 Jun 2026
Neuroactive Steroids in Brain Function, Behavior and Neuropsychiatric Disorders: Novel Strategies for Research and Treatment
81% match

Neuroactive Steroids in Brain Function, Behavior and Neuropsychiatric Disorders: Novel Strategies for Research and Treatment

Springer

£165.22 04 Aug 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
81% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£114.71 05 Aug 2026